267
Views
25
CrossRef citations to date
0
Altmetric
Review

The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML

, , , &
Pages 311-329 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ana Calheiros de Carvalho, Claudio Yoshio Ogawa$suffix/text()$suffix/text(), Luiza De Camillis Rodrigues, Lívia Soman de Medeiros & Thiago André Moura Veiga. (2021) Penicillium genus as a source for anti-leukemia compounds: an overview from 1984 to 2020. Leukemia & Lymphoma 62:9, pages 2079-2093.
Read now
Annie Guérin, Lei Chen, Katherine Dea, Eric Q. Wu & Stuart L. Goldberg. (2014) Economic benefits of adequate molecular monitoring in patients with chronic myelogenous leukemia. Journal of Medical Economics 17:2, pages 89-98.
Read now

Articles from other publishers (23)

Yadith Karina Lopez-Garcia, Mayra Valdez-Carrizales, Jorge Adrián Nuñez-Zuno, Elia Apodaca-Chávez, Juan Rangel-Patiño & Roberta Demichelis-Gómez. (2023) Are delays in diagnosis and treatment of acute leukemia in a middle-income country associated with poor outcomes? A retrospective cohort study. Hematology, Transfusion and Cell Therapy.
Crossref
Kacper Szczepski, Inas Al-Younis, Manel Dhahri, Joanna Izabela Lachowicz, Zeyad A. Al-Talla, Hanan Almahasheer, Noura Alasmael, Mahbuba Rahman, Abdul-Hamid Emwas, Łukasz Jaremko & Mariusz Jaremko. 2023. Metabolomics. Metabolomics 173 198 .
Jing Su, Liqiang Zhang, Luogen Lai, Wufu Zhu & Chong Hu. (2022) A Hemin–Graphene Nanocomposite-Based Aptasensor for Ultrasensitive Colorimetric Quantification of Leukaemia Cells Using Magnetic Enrichment. Biosensors 12:12, pages 1070.
Crossref
Reyna Aguilar Quispe, Elizabeth Marques Aguiar, Claudia Teresa de Oliveira, Ana Cristina Xavier Neves & Paulo Sérgio da Silva Santos. (2022) Oral manifestations of leukemia as part of early diagnosis. Hematology, Transfusion and Cell Therapy 44:3, pages 392-401.
Crossref
Yushun Zeng, Jia Hao, Junhang Zhang, Laiming Jiang, Sangyeon Youn, Gengxi Lu, Dongliang Yan, Haochen Kang, Yizhe Sun, K. Kirk Shung, Keyue Shen & Qifa Zhou. (2022) Manipulation and Mechanical Deformation of Leukemia Cells by High-Frequency Ultrasound Single Beam. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 69:6, pages 1889-1897.
Crossref
Chunwang Zhan, Zhiming Wu, Lihua Yang, Lihua Yu, Jie Deng, Kiuco Luk, Chongyang Duan & Luwen Zhang. (2022) Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015–2019 in Guangdong, China. BMC Health Services Research 22:1.
Crossref
Reham F. Barghash, Wagdy M. Eldehna, Markéta Kovalová, Veronika Vojáčková, Vladimír Kryštof & Hatem A. Abdel-Aziz. (2022) One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents. European Journal of Medicinal Chemistry 227, pages 113952.
Crossref
AN. Nithyaa AN. Nithyaa1, Prem Kumar R, Gokul .M Gokul .M & Geetha Aananthi C.. (2021) Matlab Based Potent Algorithm for WBc cancer Detection and classification. Biomedical and Pharmacology Journal 14:4, pages 2277-2284.
Crossref
Borhan Moradveisi, Jamal Amiri, Siamak Derakhshan, Daem Roshani & Farideh Elahimanesh. (2021) Evaluation of Risk Factors for Pediatric Cancers in the West of Iran. International Journal of Cancer Management 14:6.
Crossref
Alice J. Li, Jasper P. Dhanraj, Gilberto Lopes & Jayson L. Parker. (2020) Clinical trial risk in leukemia: Biomarkers and trial design. Hematological Oncology 39:1, pages 105-113.
Crossref
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy 547 587 .
She-Hung Chan, Wohn-Jenn Leu, Sharada Prasanna Swain, Jui-Ling Hsu, Duen-Ren Hou & Jih-Hwa Guh. (2020) Mechanistic Study of Triazole Based Aminodiol Derivatives in Leukemic Cells—Crosstalk between Mitochondrial Stress-Involved Apoptosis and Autophagy. International Journal of Molecular Sciences 21:7, pages 2470.
Crossref
Yin Shi, Zhen Zhang, Xintao Qu, Xiaoxiao Zhu, Lin Zhao, Ran Wei, Qiang Guo, Linlin Sun, Xunqiang Yin, Yunhong Zhang & Xia Li. (2018) Roles of STAT3 in leukemia (Review). International Journal of Oncology.
Crossref
Qiong Meng, Zheng Yang, Yang Wu, Yuanyuan Xiao, Xuezhong Gu, Meixia Zhang, Chonghua Wan & Xiaosong Li. (2017) Reliability analysis of the Chinese version of the Functional Assessment of Cancer Therapy – Leukemia (FACT-Leu) scale based on multivariate generalizability theory. Health and Quality of Life Outcomes 15:1.
Crossref
David Gómez-Almaguer, Edson René Marcos-Ramírez, Efreen Horacio Montaño-Figueroa, Guillermo J. Ruiz-Argüelles, Carlos Roberto Best-Aguilera, María del Carmen López-Sánchez, Esperanza Barrera-Chairez, José Luis López-Arrollo, Christian Omar Ramos-Peñafiel, Andrés León-Peña, Elías Eugenio González-López, Perla Edith Rivas-García, Carlos Alberto Tellez-Hinojosa, Andrés Gómez-De León & José Carlos Jaime-Pérez. (2017) Acute Leukemia Characteristics are Different Around the World: the Mexican Perspective. Clinical Lymphoma Myeloma and Leukemia 17:1, pages 46-51.
Crossref
Yu-Jun Wang, Chung-Chih Liao, Hsuan-Ju Chen, Ching-Liang Hsieh & Tsai-Chung Li. (2016) The Effectiveness of Traditional Chinese Medicine in Treating Patients with Leukemia. Evidence-Based Complementary and Alternative Medicine 2016, pages 1-12.
Crossref
Adrian Bloor, Erwin De Cock, Anthony J Hatswell, Radek Wasiak, Jamie Elvidge, Ceilidh Stapelkamp, Tsveta Hadjivassileva, Amin Haiderali & Julio Delgado. (2015) Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL). British Journal of Haematology 169:3, pages 449-452.
Crossref
Kevin Marsh, Peng Xu, Panagiotis Orfanos, Agnes Benedict, Kamal Desai & Ingolf Griebsch. (2014) Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Myeloid Leukaemia: A Review and Summary of Challenges. PharmacoEconomics 32:9, pages 853-864.
Crossref
Carl Rudolf Blankart, Taika Koch, Roland Linder, Frank Verheyen, Jonas Schreyögg & Tom Stargardt. (2013) Cost of illness and economic burden of chronic lymphocytic leukemia. Orphanet Journal of Rare Diseases 8:1, pages 32.
Crossref
David Cella, Sally E. Jensen, Kimberly Webster, Du Hongyan, Jin-Shei Lai, Steven Rosen, Martin S. Tallman & Susan Yount. (2012) Measuring Health-Related Quality of Life in Leukemia: The Functional Assessment of Cancer Therapy – Leukemia (FACT-Leu) Questionnaire. Value in Health 15:8, pages 1051-1058.
Crossref
Sul-Ji Choi, Ji-Young Kim, Jai-Dong Moon, Hee-Jo Baek, Hoon Kook & Sang-Beom Seo. (2011) Differential Gene Expression Analysis in K562 Human Leukemia Cell Line Treated with Benzene. Toxicological Research 27:1, pages 43-48.
Crossref
Shelagh M. Szabo, Adrian R. Levy, Catherine Davis, Tessa L. Holyoake & Jorge Cortes. (2010) A Multinational Study of Health State Preference Values Associated with Chronic Myelogenous Leukemia. Value in Health 13:1, pages 103-111.
Crossref
Grant H. Skrepnek & Erin E. Ballard. (2005) Cost-Efficacy of Imatinib versus Allogeneic Bone Marrow Transplantation with a Matched Unrelated Donor in the Treatment of Chronic Myelogenous Leukemia: A Decision-Analytic Approach. Pharmacotherapy 25:3, pages 325-334.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.